modelC10AA01

Diagram of C10AA01

Extends from Pharmacokinetic.Models.PK_2C_enteral.

Information

name:Simvastatin
ATC code:C10AA01
route:oral
compartments:2
dosage:40mg
volume of distribution:86L
clearance:51L/h
other parameters in model implementation

Simvastatin is a lipid-lowering medication of the statin class, used primarily to treat high cholesterol and reduce the risk of cardiovascular disease. It inhibits HMG-CoA reductase, a key enzyme involved in the mevalonate pathway of cholesterol synthesis. Simvastatin is approved and widely used today.

Pharmacokinetics

Pharmacokinetic parameters of simvastatin in healthy adult subjects after single oral dose administration.

References

  1. Ogungbenro, K, et al., & Galetin, A (2019). A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents. European journal of clinical pharmacology 75(9) 1227–1235. DOI:10.1007/s00228-019-02697-y PUBMED:https://pubmed.ncbi.nlm.nih.gov/31172248

  2. Kim, MS, & Baek, IH (2021). Pharmacokinetic analysis of two different doses of simvastatin following oral administration in dogs. Journal of veterinary pharmacology and therapeutics 44(3) 333–341. DOI:10.1111/jvp.12944 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33368422

  3. Zhou, Q, et al., & Zeng, S (2013). Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. Die Pharmazie 68(2) 124–128. PUBMED:https://pubmed.ncbi.nlm.nih.gov/23469684

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)